PUBLIC PERM CASES · FY2026 Q4
Hikma Pharmaceuticals USA Inc.
OFLC 披露文件中的 13 个公开案件。逐案数据按季度更新,不是实时 DOL 状态。
DOL 最近案件(实时)
季度文件不会包含季度结束后才决定的案件。输入一个该雇主的已知案号,我们扫描附近公开案号,只保留同一雇主。
G-100-25325-430505
认证Principal Scientist, Injectables Analytical Research
2025-11-21 → 2026-09-18
G-100-25325-430499
认证Senior Scientist, Analytical Research & Development
2025-11-21 → 2026-09-18
G-100-25325-430498
认证Senior Scientist, Analytical Research & Development
2025-11-21 → 2026-09-18
G-100-25322-417963
撤回Senior Scientist, Analytical Research & Development
2025-11-18 → 2025-11-21
G-100-25322-417725
撤回Principal Scientist, Injectables Analytical Research
2025-11-18 → 2025-11-21
G-100-25315-398931
撤回Senior Scientist, Analytical Research & Development
2025-11-11 → 2025-11-21
G-100-25120-923611
认证Associate Director, Injectables Formulation Development
2025-04-30 → 2026-06-08
G-100-25052-716269
认证Senior Scientist, Analytical Research & Development
2025-02-21 → 2026-05-13
G-100-25052-716254
认证Senior Scientist, Analytical Research & Development
2025-02-21 → 2026-05-12
G-100-24211-229103
认证Principal Regulatory Affairs Specialist
2024-07-29 → 2025-11-25
G-100-24208-226743
认证Principal Regulatory Affairs Specialist
2024-07-26 → 2025-11-24
G-100-24200-206609
认证Principal Scientist, Injectables Analytical Research
2024-07-18 → 2025-11-21
G-100-24177-147760
撤回Sr. Project Manager – R&D
2024-06-25 → 2025-11-03